Eintrag weiter verarbeiten
The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics
Gespeichert in:
Zeitschriftentitel: | International Journal of Genomics |
---|---|
Personen und Körperschaften: | , |
In: | International Journal of Genomics, 2018, 2018, S. 1-18 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Hindawi Limited
|
Schlagwörter: |
author_facet |
Krishnan, Preethi Damaraju, Sambasivarao Krishnan, Preethi Damaraju, Sambasivarao |
---|---|
author |
Krishnan, Preethi Damaraju, Sambasivarao |
spellingShingle |
Krishnan, Preethi Damaraju, Sambasivarao International Journal of Genomics The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics Pharmaceutical Science Genetics Molecular Biology Biochemistry |
author_sort |
krishnan, preethi |
spelling |
Krishnan, Preethi Damaraju, Sambasivarao 2314-436X 2314-4378 Hindawi Limited Pharmaceutical Science Genetics Molecular Biology Biochemistry http://dx.doi.org/10.1155/2018/5848046 <jats:p>Discoveries on nonprotein-coding RNAs have induced a paradigm shift in our overall understanding of gene expression and regulation. We now understand that coding and noncoding RNA machinery work in concert to maintain overall homeostasis. Based on their length, noncoding RNAs are broadly classified into two groups—long (>200 nt) and small noncoding RNAs (<200 nt). These RNAs perform diverse functions—gene regulation, splicing, translation, and posttranscriptional modifications. MicroRNAs (miRNAs) and PIWI-interacting RNAs (piRNAs) are two classes of small noncoding RNAs that are now classified as master regulators of gene expression. They have also demonstrated clinical significance as potential biomarkers and therapeutic targets for several diseases, including cancer. Despite these similarities, both these RNAs are generated through contrasting mechanisms, and one of the aims of this review is to cover the distance travelled since their discovery and compare and contrast the various facets of these RNAs. Although these RNAs show tremendous promise as biomarkers, translating the findings from bench to bedside is often met with roadblocks. The second aim of this review therefore is to highlight some of the challenges that hinder application of miRNA and piRNA as in guiding treatment decisions.</jats:p> The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics International Journal of Genomics |
doi_str_mv |
10.1155/2018/5848046 |
facet_avail |
Online Free |
finc_class_facet |
Chemie und Pharmazie Biologie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE4LzU4NDgwNDY |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE4LzU4NDgwNDY |
institution |
DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 |
imprint |
Hindawi Limited, 2018 |
imprint_str_mv |
Hindawi Limited, 2018 |
issn |
2314-436X 2314-4378 |
issn_str_mv |
2314-436X 2314-4378 |
language |
English |
mega_collection |
Hindawi Limited (CrossRef) |
match_str |
krishnan2018thechallengesandopportunitiesintheclinicalapplicationofnoncodingrnastheroadmapformirnasandpirnasincancerdiagnosticsandprognostics |
publishDateSort |
2018 |
publisher |
Hindawi Limited |
recordtype |
ai |
record_format |
ai |
series |
International Journal of Genomics |
source_id |
49 |
title |
The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_unstemmed |
The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_full |
The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_fullStr |
The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_full_unstemmed |
The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_short |
The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_sort |
the challenges and opportunities in the clinical application of noncoding rnas: the road map for mirnas and pirnas in cancer diagnostics and prognostics |
topic |
Pharmaceutical Science Genetics Molecular Biology Biochemistry |
url |
http://dx.doi.org/10.1155/2018/5848046 |
publishDate |
2018 |
physical |
1-18 |
description |
<jats:p>Discoveries on nonprotein-coding RNAs have induced a paradigm shift in our overall understanding of gene expression and regulation. We now understand that coding and noncoding RNA machinery work in concert to maintain overall homeostasis. Based on their length, noncoding RNAs are broadly classified into two groups—long (>200 nt) and small noncoding RNAs (<200 nt). These RNAs perform diverse functions—gene regulation, splicing, translation, and posttranscriptional modifications. MicroRNAs (miRNAs) and PIWI-interacting RNAs (piRNAs) are two classes of small noncoding RNAs that are now classified as master regulators of gene expression. They have also demonstrated clinical significance as potential biomarkers and therapeutic targets for several diseases, including cancer. Despite these similarities, both these RNAs are generated through contrasting mechanisms, and one of the aims of this review is to cover the distance travelled since their discovery and compare and contrast the various facets of these RNAs. Although these RNAs show tremendous promise as biomarkers, translating the findings from bench to bedside is often met with roadblocks. The second aim of this review therefore is to highlight some of the challenges that hinder application of miRNA and piRNA as in guiding treatment decisions.</jats:p> |
container_start_page |
1 |
container_title |
International Journal of Genomics |
container_volume |
2018 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792342185572564997 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T16:31:33.042Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+Challenges+and+Opportunities+in+the+Clinical+Application+of+Noncoding+RNAs%3A+The+Road+Map+for+miRNAs+and+piRNAs+in+Cancer+Diagnostics+and+Prognostics&rft.date=2018-01-01&genre=article&issn=2314-4378&volume=2018&spage=1&epage=18&pages=1-18&jtitle=International+Journal+of+Genomics&atitle=The+Challenges+and+Opportunities+in+the+Clinical+Application+of+Noncoding+RNAs%3A+The+Road+Map+for+miRNAs+and+piRNAs+in+Cancer+Diagnostics+and+Prognostics&aulast=Damaraju&aufirst=Sambasivarao&rft_id=info%3Adoi%2F10.1155%2F2018%2F5848046&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792342185572564997 |
author | Krishnan, Preethi, Damaraju, Sambasivarao |
author_facet | Krishnan, Preethi, Damaraju, Sambasivarao, Krishnan, Preethi, Damaraju, Sambasivarao |
author_sort | krishnan, preethi |
container_start_page | 1 |
container_title | International Journal of Genomics |
container_volume | 2018 |
description | <jats:p>Discoveries on nonprotein-coding RNAs have induced a paradigm shift in our overall understanding of gene expression and regulation. We now understand that coding and noncoding RNA machinery work in concert to maintain overall homeostasis. Based on their length, noncoding RNAs are broadly classified into two groups—long (>200 nt) and small noncoding RNAs (<200 nt). These RNAs perform diverse functions—gene regulation, splicing, translation, and posttranscriptional modifications. MicroRNAs (miRNAs) and PIWI-interacting RNAs (piRNAs) are two classes of small noncoding RNAs that are now classified as master regulators of gene expression. They have also demonstrated clinical significance as potential biomarkers and therapeutic targets for several diseases, including cancer. Despite these similarities, both these RNAs are generated through contrasting mechanisms, and one of the aims of this review is to cover the distance travelled since their discovery and compare and contrast the various facets of these RNAs. Although these RNAs show tremendous promise as biomarkers, translating the findings from bench to bedside is often met with roadblocks. The second aim of this review therefore is to highlight some of the challenges that hinder application of miRNA and piRNA as in guiding treatment decisions.</jats:p> |
doi_str_mv | 10.1155/2018/5848046 |
facet_avail | Online, Free |
finc_class_facet | Chemie und Pharmazie, Biologie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE4LzU4NDgwNDY |
imprint | Hindawi Limited, 2018 |
imprint_str_mv | Hindawi Limited, 2018 |
institution | DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1 |
issn | 2314-436X, 2314-4378 |
issn_str_mv | 2314-436X, 2314-4378 |
language | English |
last_indexed | 2024-03-01T16:31:33.042Z |
match_str | krishnan2018thechallengesandopportunitiesintheclinicalapplicationofnoncodingrnastheroadmapformirnasandpirnasincancerdiagnosticsandprognostics |
mega_collection | Hindawi Limited (CrossRef) |
physical | 1-18 |
publishDate | 2018 |
publishDateSort | 2018 |
publisher | Hindawi Limited |
record_format | ai |
recordtype | ai |
series | International Journal of Genomics |
source_id | 49 |
spelling | Krishnan, Preethi Damaraju, Sambasivarao 2314-436X 2314-4378 Hindawi Limited Pharmaceutical Science Genetics Molecular Biology Biochemistry http://dx.doi.org/10.1155/2018/5848046 <jats:p>Discoveries on nonprotein-coding RNAs have induced a paradigm shift in our overall understanding of gene expression and regulation. We now understand that coding and noncoding RNA machinery work in concert to maintain overall homeostasis. Based on their length, noncoding RNAs are broadly classified into two groups—long (>200 nt) and small noncoding RNAs (<200 nt). These RNAs perform diverse functions—gene regulation, splicing, translation, and posttranscriptional modifications. MicroRNAs (miRNAs) and PIWI-interacting RNAs (piRNAs) are two classes of small noncoding RNAs that are now classified as master regulators of gene expression. They have also demonstrated clinical significance as potential biomarkers and therapeutic targets for several diseases, including cancer. Despite these similarities, both these RNAs are generated through contrasting mechanisms, and one of the aims of this review is to cover the distance travelled since their discovery and compare and contrast the various facets of these RNAs. Although these RNAs show tremendous promise as biomarkers, translating the findings from bench to bedside is often met with roadblocks. The second aim of this review therefore is to highlight some of the challenges that hinder application of miRNA and piRNA as in guiding treatment decisions.</jats:p> The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics International Journal of Genomics |
spellingShingle | Krishnan, Preethi, Damaraju, Sambasivarao, International Journal of Genomics, The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics, Pharmaceutical Science, Genetics, Molecular Biology, Biochemistry |
title | The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_full | The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_fullStr | The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_full_unstemmed | The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_short | The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
title_sort | the challenges and opportunities in the clinical application of noncoding rnas: the road map for mirnas and pirnas in cancer diagnostics and prognostics |
title_unstemmed | The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics |
topic | Pharmaceutical Science, Genetics, Molecular Biology, Biochemistry |
url | http://dx.doi.org/10.1155/2018/5848046 |